Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.13.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.20.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.20.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.20.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.20.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.20.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.20.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.20.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.20.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HK.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.8.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.8.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.8.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.8.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.8.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.19.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.19.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.19.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.19.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.19.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.19.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.19.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.19.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JR.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JR.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JR.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JR.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JR.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JR.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JR.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JR.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.1.2.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GJ.1.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GJ.1.2.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GJ.1.2.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GJ.1.2.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GJ.1.2.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.1.2.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used